Vertex Minerals Limited (ASX:VTX) (OTCMKTS:VTXXF) is pleased to announce seven key operational appointments to progress the Company's operational plans for the high grade Reward Underground Gold Mine.

Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

March 11, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX ... The event will begin at 8:30 a.m. ET and is expected to conclude approximately 12:00 p.m. ET. Due to a limited capacity, in-person ...

Vertex Pharmaceuticals Incorporated has a twelve month low of $377.85 and a twelve month high of $519.88. The company has a quick ratio of 2.35, a current ratio of 2.69 and a debt-to-equity ratio ...

A month has gone by since the last earnings report for Vertex Pharmaceuticals (VRTX). Shares have added about 7.3% in that time frame, outperforming the S&P 500. Will the recent positive trend ...

Vertex' therapy takes the form of stem cell-derived human pancreatic islet cells, which secrete insulin in the body in response to rising blood glucose. The aim is to replace the pancreatic tissue ...

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $503.20, representing a -1.37% change from its previous close. Amicus Therapeutics (FOLD) reported earnings 30 days ago.

Overall, Angel Reese has performed well in the inaugural season of Unrivaled. That said, fans have had a field day with the second-year forward online following a recent lowlight. On Monday night ...

The CVR is contingent on the company’s product portfolio achieving $600M in net sales in any trailing 12-month period prior ... The FDA approved Lyfgenia and Vertex Pharmaceuticals' (VRTX ...

Zai Lab Limited's stock surged 105% in a year. Click to explore ZLAB's $2bn revenue goal, key drugs, and strategic ...